Open AccessODAC Says Gemzar Active in Ovarian Cancer, but Votes Against Recommending Approval Due to Poorly Designed Studies
Author(s) -
Margot J. Fromer
Publication year - 2006
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000294585.31315.92
Subject(s) - gemcitabine , carboplatin , medicine , ovarian cancer , debulking , oncology , cancer , paclitaxel , clinical trial , cisplatin , chemotherapy